|
English
|
正體中文
|
简体中文
|
總筆數 :2856565
|
|
造訪人次 :
53371390
線上人數 :
923
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
顯示項目 268086-268095 / 2348971 (共234898頁)
<< < 26804 26805 26806 26807 26808 26809 26810 26811 26812 26813 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T15:24:05Z |
Combined Transarterial Embolization and Propranolol as Effective Treatment for Hepatic Hemangioma with Kasabach-Merritt Syndrome and Heart Failure in a Neonate
|
PO-CHIN LIANG; Shen, W.-C. and Liang, P.-C. and Wu, J.-F. and Hsu, C.-T. and Chen, H.-S. and Chen, H.-L. |
| 臺大學術典藏 |
2018-09-10T15:34:38Z |
Combined Transarterial Embolization and Propranolol as Effective Treatment for Hepatic Hemangioma with Kasabach-Merritt Syndrome and Heart Failure in a Neonate.
|
Jia-Feng Wu; JIA-FENG WU |
| 臺大學術典藏 |
2020-03-10T03:29:53Z |
Combined Transarterial Embolization and Propranolol as Effective Treatment for Hepatic Hemangioma with Kasabach–Merritt Syndrome and Heart Failure in a Neonate
|
Shen W.-C.;Liang P.-C.;Wu J.-F.;Hsu C.-T.;Chen H.-S.;Huey-Ling Chen; Shen W.-C.; Liang P.-C.; Wu J.-F.; Hsu C.-T.; Chen H.-S.; HUEY-LING CHEN |
| 臺大學術典藏 |
2020-08-11T08:36:44Z |
Combined Transarterial Embolization and Propranolol as Effective Treatment for Hepatic Hemangioma with Kasabach–Merritt Syndrome and Heart Failure in a Neonate
|
Shen W.-C.; PO-CHIN LIANG; Wu J.-F.; Hsu C.-T.; Chen H.-S.; Chen H.-L. |
| 臺大學術典藏 |
2020-12-21T01:08:30Z |
Combined Transarterial Embolization and Propranolol as Effective Treatment for Hepatic Hemangioma with Kasabach–Merritt Syndrome and Heart Failure in a Neonate
|
Hsu C.-T.; JIA-FENG WU; Liang P.-C.; Shen W.-C.; Shen W.-C.;Liang P.-C.;Jia-Feng Wu;Hsu C.-T.;Chen H.-S.;Chen H.-L.; Chen H.-S.; Chen H.-L. |
| 臺大學術典藏 |
2021-05-11T05:18:55Z |
Combined Transarterial Embolization and Propranolol as Effective Treatment for Hepatic Hemangioma with Kasabach–Merritt Syndrome and Heart Failure in a Neonate
|
Shen W.-C.; Liang P.-C.; Wu J.-F.; Hsu C.-T.; HO-SHENG CHEN; Chen H.-L. |
| 國立成功大學 |
2019 |
Combined transarterial embolization/ chemoembolization-based locoregional treatment with sorafenib prolongs the survival in patients with advanced hepatocellular carcinoma and preserved liver function: A propensity score matching study
|
Chien, S.-C.;Chen, Chen C.-Y.;Cheng, P.-N.;Liu, Y.-S.;Cheng, H.-C.;Chuang, Chuang C.-H.;Chang, T.-T.;Chiu, H.-C.;Lin, Y.-J.;Chiu, Y.-C. |
| 國立成功大學 |
2019 |
Combined Transarterial Embolization/Chemoembolization-Based Locoregional Treatment with Sorafenib Prolongs the Survival in Patients with Advanced Hepatocellular Carcinoma and Preserved Liver Function: A Propensity Score Matching Study
|
Chien;Shih-Chieh;Chen;Chiung-Yu;Cheng;Pin-Nan;Liu;Yi-Shan;Cheng;Hsiu-Chi;Chuang;Chiao-Hsiung;Chang;Ting-Tsung;Chiu;Hong-Chi;Lin;Yih-Jyh;Chiu;Yen-Cheng |
| 臺北醫學大學 |
1999 |
Combined treatment effect of 5-fluorouracil with ionizing radiation on human colorectal carcinoma cells.
|
鄧文炳; Hwang; J.J.; Chen; P.Y.; Deng; W.P.; Hwang J.Y.; Lin; G.L. and Lin; F.J. |
| 國家衛生研究院 |
2024-11 |
Combined treatment of caffeic acid phenethyl ester with docetaxel inhibits survival of non-small-cell lung cancer cells via suppression of c-MYC
|
Kuo, LK;Fu, YK;Yeh, CC;Lee, CY;Chung, CJ;Shih, LJ;Lu, HY;Chuu, CP |
顯示項目 268086-268095 / 2348971 (共234898頁)
<< < 26804 26805 26806 26807 26808 26809 26810 26811 26812 26813 > >>
每頁顯示[10|25|50]項目
|
